HOME >> MEDICINE >> NEWS
NIAID Ebola vaccine enters human trial

The first human trial of a vaccine designed to prevent Ebola infection opened today. Scientists from the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH), designed the vaccine, which was administered to a volunteer at the NIH Clinical Center in Bethesda. The vaccine does not contain any infectious material from the Ebola virus.

Just three years ago, VRC Director Gary Nabel, M.D., Ph.D., together with a team of scientists from the VRC and the Centers for Disease Control and Prevention, described an experimental Ebola vaccine that fully protected monkeys from lethal infection by the virus. One component of that vaccine will now be assessed for safety in human volunteers. The trial vaccine, a type called a DNA vaccine, is similar to other investigational vaccines that hold promise for controlling such diseases as AIDS, influenza, malaria and hepatitis.

"This trial is further evidence of the ability of the VRC to rapidly translate basic research into tangible products," notes NIAID Director Anthony S. Fauci, M.D. "Our accelerated effort to understand and combat Ebola infection is part of the NIAID commitment to its biodefense mission. An effective Ebola vaccine not only would provide a life-saving advance in countries where the disease occurs naturally, it also would provide a
medical tool to discourage the use of Ebola virus as an agent of bioterrorism."

Outbreaks of Ebola in Africa kill up to 90 percent of those infected. No effective treatment exists for this highly infectious disease, which causes extensive internal bleeding and rapid death. According to experts, vaccination is the best strategy for preventing or containing this deadly infection.

A gap of two decades separated the first Ebola epidemic of 1976 and the next, which arose in 1995. In recent years, for reasons unknown, outbreaks of Ebola are occurring with increasing fre
'"/>

Contact: Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
18-Nov-2003


Page: 1 2 3

Related medicine news :

1. NIAID initiates trial of experimental avian flu vaccine
2. NIAID seeks applicants to lead clinical trials units for revamped HIV/AIDS networks
3. NIAID begins enrolling volunteers for novel HIV vaccine study
4. NIAID-sponsored clinical trial aims to boost flu vaccine supply
5. NIAID seeks applicants to lead revamped HIV/AIDS clinical trials networks
6. NIAID launches influenza genome sequencing project
7. NIAID launches program to improve medical tools against emerging infectious diseases
8. NIAID forms network to tackle potentially fatal reaction to smallpox vaccine
9. NIAID rotavirus vaccine licensed for commercialization
10. Second NIAID SARS vaccine candidate helps mice fend off SARS
11. NIAID vaccine protects against SARS virus infection in mice

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2019)... (PRWEB) , ... May 21, 2019 , ... ... for Interoperability[1], mandated by the 2015 21st Century Cure Act[2], calls for the ... for all electronic health records. The American Medical Informatics Association; however, recommends that ...
(Date:5/21/2019)... ... ... Coral Detection Systems recently went to market with the first and only drowning ... software and an underwater video camera to analyze, detect, and track all people in ... entrance to the water, and more importantly, upon detection of risk of drowning. ...
(Date:5/21/2019)... GAITHERSBURG, Md. (PRWEB) , ... May 21, 2019 , ... ... with a safe, proven and effective solution: vaccination. , Between January 1, 2019 and ... of measles across 23 states. Worryingly, this number includes a 60 case jump between ...
(Date:5/21/2019)... ... 2019 , ... CEO Steven C. Bilt of Smile Brands ... of Corporate Growth Awards last week. ACG supports middle-market dealmakers and business leaders ... support organization with over 400 affiliated practices across 17 states, has a deeply ...
(Date:5/21/2019)... (PRWEB) , ... May 21, 2019 , ... ... impact of new drugs on cognition, as any drug that crosses the blood-brain ... medications and the aging process itself can all compromise the integrity of the ...
Breaking Medicine News(10 mins):
(Date:5/21/2019)... ... May 21, 2019 , ... ... advocacy effort known as the Donor Champion Program. Created through a 3-way collaboration ... Donors Network, the Donor Champion Program was developed with transplant patients and their ...
(Date:5/21/2019)... ... May 21, 2019 , ... The evolution of the cannabis ... new product categories becoming available in the market. Large and small companies alike ... the consumer. However, there are many challenges in formulating any consumable product and ...
(Date:5/21/2019)... LOS ANGELES (PRWEB) , ... May 21, 2019 ... ... revenue cycle management (RCM) solutions to Healthcare Providers and Payers, announced today that ... Intelligence and Artificial Intelligence Conclave. , The Conference brings together hundreds of leading ...
Breaking Medicine Technology:
Cached News: